Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (281-290 of 375) with videos related to

Pageof 38
Sort By:
NPJ Breast Cancer|June 29, 2021
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Breast Cancer Research and Treatment|April 9, 2024
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in BelgiumMariana Brandão, Diogo Martins-Branco, Claudia De Angelis, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Breast (Edinburgh, Scotland)|August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectivesLeonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
Breast Cancer Research and Treatment|October 25, 2023
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in BelgiumMariana Brandão, Diogo Martins-Branco, Claudia De Angelis, et al.
Breast (Edinburgh, Scotland)|October 9, 2025
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studiesFernanda Mesa-Chavez, Maria Grazia Razeti, Eva Blondeaux, et al.
JNCI Cancer Spectrum|August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysisFrancesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
JAMA Network Open|November 16, 2023
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast CancerRayan Kabirian, Maria Alice Franzoi, Julie Havas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Pageof 38

Showing results (281-290 of 375) with videos related to

Sort By:
Pageof 38
NPJ Breast Cancer|June 29, 2021
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Breast Cancer Research and Treatment|April 9, 2024
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in BelgiumMariana Brandão, Diogo Martins-Branco, Claudia De Angelis, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Breast (Edinburgh, Scotland)|August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectivesLeonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
Breast Cancer Research and Treatment|October 25, 2023
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in BelgiumMariana Brandão, Diogo Martins-Branco, Claudia De Angelis, et al.
Breast (Edinburgh, Scotland)|October 9, 2025
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studiesFernanda Mesa-Chavez, Maria Grazia Razeti, Eva Blondeaux, et al.
JNCI Cancer Spectrum|August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysisFrancesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
JAMA Network Open|November 16, 2023
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast CancerRayan Kabirian, Maria Alice Franzoi, Julie Havas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Pageof 38